Core Laboratories N.V. (CLB) News
Filter CLB News Items
CLB News Results
|Loading, please wait...|
CLB News Highlights
- CLB's 30 day story count now stands at 10.
- Over the past 21 days, the trend for CLB's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
- The most mentioned tickers in articles about CLB are LAB, BAND and BEAT.
Latest CLB News From Around the Web
Below are the latest news stories about CORE LABORATORIES N V that investors may wish to consider to help them evaluate CLB as an investment opportunity.
Core Laboratories N.V. (NYSE:CLB) Q4 2022 Earnings Call Transcript February 2, 2023 Operator: Good morning, and welcome to the Core Laboratories Fourth Quarter 2022 Earnings Call. All participants will be in listen-only mode. . After today’s presentation, there will be an opportunity to ask questions. . Please note this event is being recorded. I would […]
Core Labs' (CLB) revenues for the first quarter of 2023 are anticipated in the $125-$129 million range, while the operating income is estimated in the $11.5-$14.5 million band.
This morning, I'm joined by Chris Hill, Core's chief financial officer; and Gwen Gresham, Core's senior vice president and head of investor relations. Gwen will start by making remarks regarding forward-looking statements.
Core Laboratories (CLB) delivered earnings and revenue surprises of 5.26% and 1.83%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Core Laboratories N.V. (NYSE: CLB) ("Core", "Core Lab", or the "Company") reported fourth quarter 2022 revenue of $127,600,000. Core's operating income was $15,600,000, with diluted earnings per share ("EPS") of $0.14, all in accordance with U.S. generally accepted accounting principles ("GAAP"). The financial results for the fourth quarter of 2022 include a non-cash adjustment of $1,900,000, decreasing stock compensation expense associated with performance share awards that vested during the qu
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Core Labs plans to relocate from the Netherlands to the United States to increase shareholder value over time by streamlining its corporate structure, enhancing operational effectiveness and reducing cost.
In Wednesday’s session, Core Laboratories N.V. (NYSE:CLB) marked $23.75 per share, down from $24.15 in the previous session. While Core Laboratories N.V. has underperformed by -1.66%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CLB fell by -13.16%, with highs and lows ranging from $35.83 to […]
Core Laboratories (CLB) said Tuesday it plans to reorganize its corporate structure, including redomestication to the U.S. from the Netherlands.
Core Laboratories N.V. (NYSE: "CLB US") ("Core", "Core Lab", or the "Company") announces the Company's Board of Directors has approved a plan to reorganize the Company's corporate structure, which will include redomestication of the parent company from the Netherlands to the United States (the "Redomestication"). The Company and its Board believes that the Redomestication will enhance shareholder value over the long-term through simplifying the corporate structure, improving operational efficien